Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.
Sleep Health in the Rural South and Its Relationships With Cardiometabolic Health Disparities
2 other identifiers
observational
3,680
1 country
1
Brief Summary
Rural communities in the southern U.S. suffer a disproportionate burden of morbidity and mortality from cardiometabolic disease, with traditional risk factors explaining only a modest proportion of the excess burden of disease. There is considerable evidence that multiple dimensions of sleep health, including sleep duration, efficiency, timing, and regularity, as well as the disorders sleep apnea and insomnia, affect cardiometabolic disease risk. However, there is currently a lack of systematically developed sleep data in rural populations. The RURAL Sleep Study is an ancillary study to a recently initiated longitudinal epidemiology study in rural Appalachia and Mississippi Delta (the RURAL Study). The RURAL Sleep Study will add measures of sleep health to the complex individual, social and environmental factors and health outcome measures being evaluated by the RURAL Study, by incorporating minimally burdensome measures of multiple dimensions of sleep health. The results are expected to inform health care providers, public health officials, and the general public of the prevalence, risk factors, and consequences of impaired sleep health in these rural communities, providing a critical basis for prevention, recognition, and management of sleep disorders and improvement of sleep and cardiometabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2024
CompletedFirst Posted
Study publicly available on registry
March 28, 2024
CompletedStudy Start
First participant enrolled
May 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
October 27, 2025
October 1, 2025
2.7 years
March 22, 2024
October 23, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Oxygen desaturation index
Frequency of 4% drops in nocturnal blood oxygen saturation
7 nights
Insomnia Severity Index
min: 0, max: 28, higher score indicates more insomnia symptoms
Single measurement at baseline
Sleep Duration
Mean total sleep time from accelerometry
3-6 months
Sleep Duration Regularity
Variability in total sleep time from accelerometry
3-6 months
Sleep Timing
Sleep midpoint from accelerometry
3-6 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep-related Impairment Short Form 8a
raw score min: 8, max: 40; higher score indicates greater impairment
Single measurement at baseline
Secondary Outcomes (5)
Restless Legs Syndrome (RLS)
Single measurement at baseline
Chronotype
Single measurement at baseline
Sleep Timing Regularity
7 days
Global Sleep Quality
Single measurement at baseline
Oxygen desaturation index, 3%
7 days
Eligibility Criteria
The cohort will consist of a general population sample of adults age 25-64 years residing in 10 counties in the rural Appalachia and Mississippi Delta regions (AMD): Alabama, Mississippi, Louisiana, and Kentucky, with counties sampled proportional to their populations. The projected RURAL Study sample size is 4600 individuals, with approximately equal numbers in each of the four age deciles. The sample is anticipated to include 51.7% women and 48.3% men. The projected racial/ethnic make-up of the sample is 63.8% non-Hispanic white, 32.7% non-Hispanic black, 1.7% Hispanic and 1.8% other.
You may qualify if:
- All participants in the Risk Underlying Rural Areas Longitudinal (RURAL) Study will be eligible for enrollment in this ancillary study.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- University of Alabama at Birminghamcollaborator
- Emory Universitycollaborator
- University of Pennsylvaniacollaborator
- University of Massachusetts, Worcestercollaborator
- The University of Texas Health Science Center at San Antoniocollaborator
- Beth Israel Deaconess Medical Centercollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel J Gottlieb, MD, MPH
Brigham and Women's Hospital
- PRINCIPAL INVESTIGATOR
Tené Lewis, PhD
Emory University
- PRINCIPAL INVESTIGATOR
Tianyi Huang, PhD
Harvard Chan School of Public Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
March 22, 2024
First Posted
March 28, 2024
Study Start
May 8, 2024
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
October 27, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Within one year of publication of primary study results.
De-identified oximetry data and the results of sleep questionnaires will be shared via the National Sleep Research Resource (NSRR) (sleepdata.org). The RURAL sleep data will be available for any researcher who provides an acceptable Data Access and Use Agreement and has appropriate regulatory approvals. The NSRR has procedures to streamline Institutional Review Board (IRB) approval (via an in house IRB process). The NSRR is in the process of migrating to Bio Data Catalyst, enabling easy linkage and interoperability with other Bio Data Catalyst data (from RURAL) and other cohorts to individuals with approved Database of Genotypes and Phenotypes (dbGaP) authorization. Other RURAL Study data that are integral to this project but were collected separately by the parent RURAL Study (e.g., non-sleep cardiovascular risk and outcomes data) will be distributed via RURAL Study data sharing mechanisms, including via Bio Data Catalyst and dbGaP.